Pessente Gabrielle D'Arezzo, Sacilotto Luciana, Calil Zaine Oliveira, Olivetti Natalia Quintella Sangiorgi, Wulkan Fanny, de Oliveira Théo Gremen Mimary, Pedrosa Anísio Alexandre Andrade, Wu Tan Chen, Hachul Denise Tessariol, Scanavacca Maurício Ibrahim, Krieger José Eduardo, Darrieux Francisco Carlos da Costa, Pereira Alexandre da Costa
Laboratory of Genetics and Molecular Cardiology (LGMC) - Heart Institute (Institute Coração, University of São Paulo Medical School, São Paulo, Brazil.
Arrhythmia Unit - Heart Institute (Institute Coração), University of São Paulo Medical School, São Paulo, Brazil.
Front Cardiovasc Med. 2022 Apr 5;9:823717. doi: 10.3389/fcvm.2022.823717. eCollection 2022.
Mutations in the ) gene are commonly associated with cardiac manifestations, such as dilated cardiomyopathy (DCM) and conduction system disease. However, the overall spectrum and penetrance of rare variants are unknown. The present study described the presence of in patients with "lone atrial fibrillation (AF)" as their sole clinical presentation.
One-hundred and one consecutive patients with "lone AF" criteria were initially screened by genetic testing. Genetic variants were classified according to the American College of Genetic and Genomic criteria. All subjects were evaluated through clinical and familial history, ECG, 24-h Holter monitoring, echocardiogram, cardiac magnetic resonance, treatment response, and the present relatives of carriers. In addition, whole-exome data from 49,960 UK Biobank (UKB) participants were analyzed to describe the overall penetrance of rare missense and loss of function (LOF) variants.
Three missense variants in were identified in probands with AF as their first and unique clinical manifestation. Other five first-degree relatives, after the screening, also presented gene variants. Among 49,960 analyzed UKB participants, 331 carried rare missense or LOF variant. Participants who carried a rare variant were significantly associated with higher odds of arrhythmic events and of an abnormal ECG in the per-protocol ECG exam ( = 0.03 and = 0.05, respectively).
Although a rare occurrence, our findings emphasize the possibility of an initial presentation of apparently "lone AF" in gene variant carriers.
(某)基因的突变通常与心脏表现相关,如扩张型心肌病(DCM)和传导系统疾病。然而,罕见变异的总体谱和外显率尚不清楚。本研究描述了以“孤立性房颤(AF)”为唯一临床表现的患者中(该基因变异)的存在情况。
对101例符合“孤立性AF”标准的连续患者进行基因检测初筛。基因变异根据美国遗传与基因组学学会标准进行分类。通过临床和家族史、心电图、24小时动态心电图监测、超声心动图、心脏磁共振成像、治疗反应以及携带者的现存亲属对所有受试者进行评估。此外,对来自49960名英国生物银行(UKB)参与者的全外显子数据进行分析,以描述罕见的错义变异和功能丧失(LOF)变异的总体外显率。
在以AF为首发且唯一临床表现的先证者中鉴定出三个错义变异。另外五名一级亲属在筛查后也出现了(该)基因变异。在49960名接受分析的UKB参与者中,331人携带罕见的错义或LOF变异。携带罕见(该)变异的参与者在符合方案的心电图检查中发生心律失常事件和心电图异常的几率显著更高(分别为P = 0.03和P = 0.05)。
尽管发生率较低,但我们的研究结果强调了(该)基因变异携带者最初表现为明显“孤立性AF”的可能性。